Press Releases PMV Pharmaceuticals, Inc.

Equities

PMVP

US69353Y1038

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
2.04 ^USD	-2.86%		+2.51%	-34.19%

09/05	PMV Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
12/04	Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights	09/05	AQ
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors	27/03	AQ
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer	19/03	AQ
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights	01/03	AQ
PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference	26/02	AQ
PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway	19/01	AQ
PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development	06/01	AQ
PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights	09/11	AQ
PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation	12/23/12	AQ
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar	11/23/11	AQ
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	21/23/21	AQ
PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights	09/23/09	AQ
PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference	07/23/07	AQ
PMV PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10/23/10	AQ
PMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights	10/23/10	AQ
PMV PHARMACEUTICALS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	28/23/28	AQ
PMV PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	01/23/01	AQ
PMV Pharmaceuticals Reports Full Year 2022 Financial Results and Corporate Highlights	01/23/01	AQ
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in March	01/23/01	AQ
PMV Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference	22/22/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases PMV Pharmaceuticals, Inc.

Equities

PMVP

US69353Y1038

Press Releases

Filters